1 |
Gold MR, Siegel JE, Russell LB, et al (1996). Cost-Effectiveness in Health and Medicine. Oxford University Press, Oxford, UK.
|
2 |
Greenberg D, Fang C, Cohen JT, et al (2009). Preferences for Preferences. ISPOR 12th Annual European Congress, PMC56.
|
3 |
Hashimoto H (1998). Economic evaluation of health: theories and underlying assumptions. Jpn J Health Econ Pol, 8, 53-65.
|
4 |
Kobayashi M, Ohno T, Noguchi W, et al (2009). Psychological distress and quality of life in cervical cancer survivors after radiotherapy: do treatment modalities, disease after medical, and self-esteem influence outcomes? Int J Gynecol Cancer, 19, 1264-8.
DOI
ScienceOn
|
5 |
Korfage IJ, van Ballegooijen M, Wauben B, et al (2012). Having a Pap smear, quality of life before and after cervical screening: a questionnaire study. BJOG, 119, 936-44.
DOI
|
6 |
Konno R (2010). Efficient combination of primary and secondary prevention in cervical cancer. San Fujinkna no Zissai, 59, 553-8 (in Japanese).
|
7 |
Konno R, Sasagawa T, Fukuda T, et al (2010). Cost-effectiveness analysis of prophylactic cervical cancer vaccination in Japanese women. Int J Gynecol Cancer, 20, 385-92.
DOI
|
8 |
Lang HC, Chang K, Ying YH (2012). Quality of life, treatments, and patients' willingness to pay for a complete remission of cervical cancer in Taiwan. Health Econ, 21, 1217-33.
DOI
|
9 |
Matsuda A, Matsuda T, Shibata A, et al (2013). Cancer incidence and incidence rates in Japan in 2007: a study of 21 population-based cancer registries for the monitoring of cancer incidence in Japan (MCIJ) project. Jap J of Clinic Onc, 43, 328-36.
DOI
ScienceOn
|
10 |
Ministry of Health, Labour and Welfare, Japan. Vital Statistics Japan (2012). http://ganjoho.jp/professional/statistics/statistics. html (26th November 2013).
|
11 |
Ohara-Hirano Y, Kaku T, Hirakawa T, et al (2004). Uterine cervical cancer: a holistic approach to mental health and it's socio-psychological implications. Fukuoka Igaku Zasshi, 95, 183-94 (in Japanese).
|
12 |
Singer S, Kuhnt S, Momenghalibaf A, et al (2010). Patients' acceptance and psychometric properties of the EORTC QLQCX24 after surgery. Gynecol Oncol, 116, 82-7.
DOI
|
13 |
Suzuki N, Ninomiya M, Maruta S, et al (2011). Psychological characteristics of Japanese gynecologic cancer patients after learning the diagnosis according to the hospital anxiety and depression scale. J Obstet Gynaecol Res, 37, 800-8.
DOI
|
14 |
Tamura M, Nozaki M, Fukuda T (1996). An empirical study on utility assessment methods for quality adjusted life years (QALYs). Jpn J Health Econ Pol, 3, 87-103.
|
15 |
The Japanese EuroQol Translation Team (1998). The development of Japanese EuroQol instrument. J Health Care Soc, 8, 109-24 (in Japanese).
|
16 |
Westra TA, Stirbu-Wagner I, Dorsman S, et al (2013). Inclusion of the benefits of enhanced cross-protection against cervical cancer and prevention of genital warts in the costeffectiveness analysis of human papillomavirus vaccination in the Netherlands. BMC Infect Dis, 13, 75.
DOI
|
17 |
Yamamoto N, Mori R, Jacklin P, et al (2012). Introducing HPV vaccine and scaling up screening procedures to prevent deaths from cervical cancer in Japan: a cost-effectiveness analysis. BJOG, 119, 177-86.
DOI
|
18 |
zur Hauzen H (1991). Human papillomaviruses in the pathogenesis of anogenital cancer. Virology, 184, 9-13.
DOI
ScienceOn
|
19 |
Canfell K, Chesson H, Kulasingam SL, et al (2012). Modeling preventative strategies against human papillomavirus-related disease in developed countries. Vaccine, 30, 157-67.
DOI
|
20 |
Cancer Statistics Japan Editorial Board. Cancer Statistics in Japan (2009). http://ganjoho.jp/professional/statistics/backnumber/2009_jp.html (11st February 2014).
|
21 |
De Wit GA, Busschbach JJ, De Charro FT (2000). Sensitivity and perspective in the valuation of health status: whose values count? Health Econ, 9, 109-26.
DOI
|
22 |
Drummond MF, O'Brien BJ, Stoddart GL, et al (1997). Methods for the Economic Evaluation of Health Care Programmes, Second Edition. Oxford University Press, Oxford, UK.
|
23 |
Ferlay J, Soerjomataram I, Ervik M, et al (2012). GLOBOCAN 2012, Cancer Incidence and Mortality Worldwide, Version 1.0, IARC CancerBase No. 11. http://globocan.iarc.fr (10th December 2013).
|
24 |
Galante J, Augustovski F, Colantonio L, et al (2011). Estimation and comparison of EQ-5D health states' utility weights for pneumococcal and human papillomavirus diseases in Argentina, Chile, and the United Kingdom. Value Health, 14, 60-4.
|